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Abstract
Background Effective management of minor ailments in community pharma-
cies could reduce the burden on alternative high-cost services (general prac-
tices, Emergency Departments). Evidence is needed regarding the
appropriateness of management of these conditions in community pharmacies.
Objective To explore the appropriateness of minor ailment management in
community pharmacies.
Setting Prospective, observational study of simulated patient (SP) visits to
community pharmacies in Grampian (Scotland) and East Anglia (England).
Method Eighteen pharmacies (nine per centre) were recruited within a 25-mile
radius of Aberdeen or Norwich. Consultations for four minor ailments were
evaluated: back pain; vomiting/diarrhoea; sore throat; and eye discomfort. Each
pharmacy received one SP visit per ailment (four visits/pharmacy; 72 visits
total). Visits were audio-recorded and SPs completed a data collection form
immediately after each visit.
Primary Outcome Measure Each SP consultation was assessed for appropriate-
ness against product licence, practice guidelines and study-specific consensus
standards developed by a multi-disciplinary consensus panel.
Results Evaluable data were available for 68/72 (94.4%) visits. Most (96%) vis-
its resulted in the sale of a product; advice alone was the outcome of three vis-
its. All product sales complied with the product licence, 52 (76%) visits
complied with practice guidelines and seven visits achieved a ‘basic’ standard
according to the consensus standard.
Conclusion Appropriateness of care varied according to the standard used.
Pharmacy-specific quality standards are needed which are realistic and relevant
to the pharmacy context and which reflect legal and clinical guidelines to pro-
mote the safe and effective management of minor ailments in this setting.
Introduction
Emergency Departments (EDs) and general practices are
overwhelmed by demand, due in part to patients present-
ing with conditions suitable for management by other ser-
vice providers, including community pharmacists and
their teams.[1,2] Recent estimates suggest that 5% of ED
visits and 13% of general practice visits in the UK are for
minor ailments that could have been managed in commu-
nity pharmacies.[3,4] At the same time, there is evidence
from academic[5,6] and commercial investigations[7] of
low-quality management of these consultations in
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community pharmacies involving suboptimal advice or
inappropriate sales. These findings are of concern at a
time when there is increasing interest in promoting the
advisory role of the community pharmacist in addition to
the technical supply function.[8]
This study was part of the 2-year MINA research pro-
gramme,[4] which derived evidence to inform the future
delivery of minor ailment services in community pharma-
cies in the UK.
Aim
The aim of this study was to explore the appropriateness
(process and outcome) of minor ailment management in
community pharmacies using simulated patients (SPs).
Method
Design and setting
A prospective, observational design was used and included
community pharmacies in Grampian (Scotland) and East
Anglia (England). SP visits tested the management of four
minor ailments.
Recruitment of community pharmacies
Eighteen pharmacies were required (nine each from
Grampian and East Anglia), to give a wide variation in
terms of type (independent, multiple) and location
(urban, rural). All community pharmacies within a 25-
mile radius of the main city in each centre (Aberdeen
(n = 35), Norwich (n = 30)) were identified from Health
Board (Scotland) and local lists and study invitation
packs were mailed. Pharmacies were excluded if they had
participated in earlier phases of the MINA programme.[4]
Interested pharmacies were stratified by type and location
and randomly selected to generate the sample. Signed
informed consent was sought from the lead pharmacist
within each participating pharmacy. Non-pharmacist staff
could opt out of participation if preferred.
Scenario development
The four minor ailments that occur with the highest fre-
quency in EDs and general practices[3,4,9] were chosen for
scenario development; they were back pain, vomiting and
diarrhoea, sore throat and eye discomfort. A standardised
scenario for each minor ailment (Table 1) was developed
for the SP visits by a 28-person multi-disciplinary consen-
sus panel[4] (see later). Each scenario was derived from
actual consultations which occurred during an earlier
phase of the MINA programme.[9]
Simulated patients and consultations
Ten SPs (one per scenario plus one reserve per centre)
were recruited from existing SP groups in the Medical
Schools at the Universities of Aberdeen and East Anglia.
A 4-h training session, informed by previous studies,[10]
was delivered at each centre. Training focused on deliver-
ing a standardised performance while responding natu-
rally to pharmacy personnel questions.[11] Each SP was
trained to perform one scenario and wore a hidden
microphone to digitally record their consultations. To
minimise the risk of detection and any resulting
Hawthorne effect,[12] pharmacy staff were blind to the
timing and number of SP visits, as well as the ailments
that would be tested. The order of SP visits to pharmacies
was randomised. Participating pharmacists and pharmacy
assistants wore study badges throughout the study period
to ensure that SPs did not consult non-participating staff.
SPs distinguished pharmacy staff from pharmacists by
uniforms worn and company name badges. Each phar-
macy was supplied with reply-paid postcards to complete
(date/time/visit details) and return to the research team,
if they suspected receiving an SP visit. Participating phar-
macies were scheduled to receive one SP visit per minor
ailment, i.e. four visits per pharmacy (72 visits in total)
over an 8-week period (February–March 2013).
Primary outcome measure
The appropriateness of the content and outcome of each
SP visit was assessed against three standards:
 the summary of product characteristics (SPC) if a pro-
duct was sold/supplied;
 clinical guidelines;
 and a consensus standard (comprising consultation pro-
cess and outcome) (developed by the multi-disciplinary
consensus panel).
Manufacturers’ SPCs describe medicinal product prop-
erties and the conditions for their use. Existing clinical
guidelines were identified for the management of the con-
ditions presented in each of the four scenarios. These
included guidelines from SIGN (Scottish Intercollegiate
Guidelines Network), NICE (National Institute for Health
and Clinical Excellence), NHS Inform (a national health
information service in Scotland), and the Royal Pharma-
ceutical Society (Table 2).
Scenario-specific consensus standards (which included
process and outcome) were developed by the multi-disci-
plinary consensus panel which comprised community
pharmacists (n = 8), ED consultants (n = 4), ED nurses
(n = 4), GPs (n = 4), practice nurses (n = 4) and lay
members (n = 4) from Scotland, England, Northern Ireland
and Wales. Panel members operated independently and
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the process was conducted by email. An outline scenario
was developed for each of the four minor ailments which
included a list of possible consultation components in
terms of content (information gathering/provision),
including questions from the aide memoire known as
‘WWHAM’[13] (Who is it for?; What are the symptoms?;
How long have the symptoms been present?; Any medica-
tion tried already?; what Medication used currently?), and
likely outcomes (product sale, advice provision).
Panel members were asked to add any items that they
perceived would be relevant or important to include in a
pharmacy consultation for each scenario. The responses
were collated and then fed back to panel members who
were asked to indicate which components they considered
represented ‘basic’ or ‘good’ practice standards for the
management of the four conditions in a community phar-
macy (Table 3) in terms of process and outcome. Con-
sensus was defined as ≥60% agreement between panel
members (i.e. ≥17/28) for both ‘basic’ or ‘good’ consulta-
tion management. Only items where the consensus
threshold was met were included in the final standard.
When using these standards to assess SP consultations, all
components had to be delivered for the consultation to
meet the consensus standard for process.
Table 1 Simulated patient scenario
Scenario 1 Scenario 2 Scenario 3 Scenario 4
Back pain Sore throat Vomiting & diarrhoea Eye discomfort
Presentation: I need something
for my back (female)
Presentation: I need
something for a
sore throat (male)
Presentation: I need
something for vomiting
and diarrhoea (female)
Presentation: I need something
for my eye (female)
Symptoms, If asked;
Pain in her lower back
The pain began this morning
when she bent over to pick
up her trousers
The pain is on both sides of her
lower back, and has continued
on and off since, when bending
and coughing
No other symptoms; feels well
otherwise
Symptoms, If asked;
Had sore throat
for four days
Yellow/green
coloured phlegm
Not able to eat
anything, but trying
to drink
Also has headache
Feels a bit hot
Symptoms, If asked;
Had vomiting and
diarrhoea for two days
Not able to eat
anything, but drinking
Don’t have a temperature
No blood in stools
Symptoms, If asked;
Discomfort in eye
No visual disturbance
Awoke today with a red, crusty
eye, but it seems to have improved
a bit
No idea what could have caused this
No other symptoms; otherwise well
History, if asked;
38 years old
Doesn’t usually have a
problem back
No previous trauma
No sudden weight loss
No relevant lifestyle issues
Current job doesn’t involve
physical work
Nothing alleviates or worsens
the symptoms
No other medical conditions
History, if asked;
61 year old
Doesn’t smoke
Gets quite a lot
of sore throats
Doesn’t have any
chronic respiratory
illnesses, like asthma,
sinusitis, bronchitis,
COPD or emphysema
History, if asked;
55 year old
Son was vomiting at the
weekend, but nobody
else in the family has it
Doesn’t get this sort
of thing often
Hasn’t been abroad recently
No other medical conditions
History, if asked;
In her sixties
No previous eye problems
Nobody else in the household has
got it
Doesn’t wear contact lenses
No other medical conditions
Treatment, if asked;
Not using any medicines
No known drug allergies
No action taken
No simple analgesia at home
Treatment, if asked;
Not using any medicines
No known drug allergies
Has taken paracetamol for
headache and sucking
cough sweets to ease throat
Treatment, if asked;
Not using any medicines
No known drug allergies
No action taken
Table 2 Medication suggested by professional guidelines
Minor ailment Guideline Medication suggested by guideline
Back pain NICE Guideline
CG88[31] &
NHS Inform
Regular paracetamol, if insufficient
advice NSAIDS or weak opioids
Sore throat NHS Inform
& SIGN
guidelines[16]
Recommend ibuprofen and
paracetamol as a first line of
treatment for sore throats
Vomiting and
diarrhoea
NHS Inform[17] Keep hydrated. Advocates the
use of anti-diarrhoea medication
Eye discomfort RPS[18] Indicates ‘marginal benefit with
chloramphenicol’, but does not
discourage it’s use
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Data collection
There were two components to the data collection; the
digital recordings of the consultation (see above) and a
data collection form completed after every visit by the SP.
This included:
 Staff involved (pharmacist/counter staff)
 Questions asked
 Outcome of visit (medication/advice supplied)
 Perceived professionalism of staff involved (5-point
scale)
 Overall satisfaction with visit (5-point scale)
 Number of other customers on premises (as a marker
of busyness)
 Duration of the visit (from digital recorder)
Assessment of the management of minor
ailments presented during SP visits
Three researchers (JI, JC and JB) independently validated
the data from the data collection forms against digital
recordings for quality assurance purposes. Each researcher
listened to each digital recording and compared their
interpretations with the SP data collection forms. There
were few discrepancies and consensus was defined as
when two out of three researchers were in agreement.
Data management and analysis
All data were entered into SPSS version 20.[14] Indepen-
dent accuracy checks were performed on 10% of the data.
The results are presented as descriptive statistics.
Ethical approval
Ethical approval was granted by the College of Life
Sciences and Medicine Ethics Review Board, University of
Aberdeen.
Results
Twenty pharmacies (31% (20/65)) consented to partici-
pate; 18 were selected (independent (6), small chain (4)
and large chain (8)). Pharmacies were located in urban
(5) and suburban (7) areas and small towns (6).
All planned SP visits (n = 72) were completed. Two
pharmacies reported ‘suspected’ SP visits, one of which
corresponded to an actual visit; data from this visit
were excluded from analysis. Digital data were unavail-
able for three visits (due to recording problems), so
these were also excluded from the analysis. Evaluable
data were available for 68/72 (94.4%) visits. Most (96%
n = 65) visits resulted in the sale of a product; advice
alone was the outcome of three visits. One-third of vis-
its involved interaction with a pharmacist only. Most
visits were conducted when the pharmacies had <3 cus-
tomers and most SPs waited between 1 and 5 min for
their consultation. Three visits lasted more than five
minutes (Table 4).
Appropriateness of consultation process
and outcome
All product sales (outcome) complied with the product
licence, 52 (76%) visits complied with practice guideli-
nes and seven visits achieved a ‘basic’ standard accord-
ing to the consensus standard for process (Tables 5 and
6). No consultation achieved a ‘good’ standard of prac-
tice for process. In terms of the content of SP consul-
tations, the extent to which WWHAM[15] components
were elicited varied substantially across scenarios (Fig-
ure 1).
Back pain (n = 17): In terms of products sold, all the
back pain scenario visits resulted in appropriate outcomes
when assessed against both the clinical guidelines and
consensus panel standard (Table 5).
Sore throat (n = 17): The SIGN guideline[16] states that
there is no good quality evidence for non-prescription
throat sprays, lozenges or gargles. No visit complied with
the clinical guidelines because they all resulted in the sale
of at least one of these products. In contrast, however, all
sales complied with the ‘basic’ consensus standard in
terms of outcome, i.e. products sold.
Vomiting and diarrhoea (n = 17): Ten consultations
complied with NHS Inform guidelines[17] which advocate
the use of an anti-diarrhoeal product. Six SP visits
resulted in the sale of anti-nausea or anti-emetic prod-
ucts, the use of which was not supported by the guideline.
Only one consultation fulfilled the basic consensus stan-
dard for outcome which advocated advice only.
Eye discomfort (n = 17): Eleven consultations resulted
in the sale of chloramphenicol products (suggested as
having marginal benefit in the RPSGB guideline[18]). One
visit resulted in advice only and was therefore compliant
with the ‘basic’ outcome standard advocated by the con-
sensus panel. Five other consultations resulted in other
eye products being sold.
General professionalism and satisfaction
SPs rated the visits highly in terms of the general pro-
fessionalism of pharmacy staff involved in their consul-
tation (Table 6). High levels of satisfaction (very
satisfied/satisfied) were also reported. Of the eight visits
where the SP was not satisfied, six involved the same
SP.
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Table 3 Consultation components to represent ‘basic’ and ‘good’ practice as recommended by the multidisciplinary consensus panel
Scenario 1: Back pain Scenario 2: Sore throat Scenario 3: Vomiting & diarrhoea Scenario: 4 Eye discomfort
What are the symptoms? What are the symptoms? What are the symptoms? What are the symptoms?
Who is the patient? How long have the symptoms
been present?
Who is the patient? How long have the symptoms
been present?
How long have the
symptoms
been present?
Are any other medications
being used (for other
conditions)?
How long have the
symptoms been present?
Is this patient a contact lens
wearer?
Are any other
medications being used
(for other conditions)?
Advise re. symptoms and action
if symptoms continue
Are any other medications
being used (for other
conditions)?
Ensure advice re no contact
lenses until condition resolved
and ensure good cleaning of
lenses if not disposable
Does the patient
have other
medical conditions?
Timescale defined (no
improvement after 3 period
referral advised)
Does the patient have
other medical conditions?
Who is the patient?
Dosage instructions (if
medication has been
recommended)
Who is the patient? Has the patient stopped
taking oral fluids?
Dosage instructions (if
medication has been
recommended)
Advise re. symptoms
and action
if symptoms continue
How old is the patient? Advise re hydration/fluids Advise re. symptoms and
action if symptoms continue
Does the patient have
any other
symptoms?
Has any action been taken? Advise re. symptoms and
action if symptoms
continue
Timescale defined (no
improvement after 9 period
referral advised)
Has any action been taken? Does the patient have other
medical conditions?
Dosage instructions (if
medication has been
recommended)
Has any action been taken?
Does anything alleviate or
worsen symptoms
Is there any associated
temperature?
Has any action been taken? Are any other medications being
used (for other conditions)?
Check understanding Does the patient have a history
of chronic or recurrent sinusitis?
Have they tried non-prescribed
over the counter, herbal
or home remedies?
Does the patient have other
medical conditions?
Ask if already have simple
analgesia at home?
Does the patient have a chronic
respiratory illness?
Any other members of the
household affected?
Have they had previous eye
problems e.g. scleritis/iritis?
Relevant product
information (if a
product recommended)
Does the patient have any
other symptoms?
Does the patient have any
other symptoms?
Ensure there is no pain from
within the eye, and that there
exists no disturbances from
bright lights. (Rule out iritis)
If anti-inflammatories suggested
check contra indications
Check understanding Has there been any recent
travel e.g. Overseas?
Is there a history of possible
foreign body/eye abrasion
Encourage early mobilisation for
muscular back pain
Relevant product information
(if a product recommended)
Is there any blood present
in the stools (faeces)?
Are there any other members of
the household affected?
Refer to GP ‘if symptoms persist’ Dosage instructions (if medication
has been recommended)
Do you have a temperature? Is the patient using the children’s
medication?=112)
Ask if there are any questions Blood in stools - if so refer to GP Advise about actions to
prevent spread of infection
Are there any clinical signs of
dehydration? - reduced
urine output, tachycardia?
Advice about hygiene within the
household and not re-infecting
family members (cross infection)
Check understanding Check understanding
Timescale defined (no
improvement after 9 period
referral advised)
Advice about self limiting nature
of viral or bacterial conjunctivitis
in otherwise healthy individuals
Advise about actions to prevent
spread of infection
Relevant product information
(if a product recommended)
Advise about handwashing/food
contact etc.
Bold text represents ‘basic’ consultation requirements of the Multi-disciplinary Consensus Panel. Normal print represents additional requirements
to reflect a ‘good’ consultation.
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Discussion
Summary
The appropriateness of the SP visits in terms of process and
outcome varied according to the standard used. All SP con-
sultations complied with the SPCs. The majority (n = 76%)
of visits also complied with clinical guidelines. Few consul-
tations reflected the standards defined by the consensus
panel, particularly in terms of information gathering.
Strengths and limitations
Discrepancies have previously been shown to exist
between self-reported and actual recorded data,[19] but in
this study, the digital recordings provided objective data
for analysis. Non-verbal communication is an important
component of healthcare consultations,[20] but was not
assessed in this study. Duplicate, independent data extrac-
tion and assessment reduced the risk of assessor bias.
The inclusion of different types and locations of phar-
macies in two countries with different pharmacy service
contracts increased the generalisability of the results.
Pharmacies self-selected to participate in the study. No
data were collected from the non-participants. It is possi-
ble that the participating pharmacies may have had higher
levels of appropriate practice compared with non-partici-
pants and as such, the results may overestimate appropri-
ate practice across all pharmacies. Furthermore, the
inclusion of pharmacies within a 25-mile radius of the
study centre may not be comparable with national data
due to the omission of rural pharmacies. Female cus-
tomers are higher users of pharmacies than males, there-
fore, to maximise face validity, most of the SPs in this
study were female. However, there is evidence to suggest
that patient gender can influence the type of information
given by pharmacists during counselling.[21] Pharmacist/
counter assistant gender may also influence communica-
tion during consultations[22], but pharmacy personnel
gender was not recorded in this current study.
General discussion
This study clearly demonstrates that the choice of stan-
dard impacts substantially on the assessment of appropri-
ateness. To the best of our knowledge, this has not been
reported previously and is a novel finding of our study.
Some of the clinical guidelines and consensus standards
(for outcome) conflicted with the broader SPC indica-
tions. It is unclear to what extent the clinical guidelines
used in this study are referred to routinely in community
pharmacy practice. No condition-specific clinical guideli-
nes were identified that had been developed for use inT
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Table 5 Assessment of SP consultation outcomes against the summary of product characteristics, guidelines and consensus list proposed
outcome
Scenario
Appropriateness of outcome compared with:
Back pain
(N = 17)
% (n)
Sore throat
(N = 17)
% (n)
Vomiting &
diarrhoea
(N = 17) % (n)
Eye discomfort
(N = 17)
% (n)
Consensus list proposed outcome 100 (17) 100 (17) 15.8 (1) 15.8 (1)
Summaries of product characteristics 100 (17) 100 (17) 100 (17) 100 (17)
NICE Guideline[30] 100 (17)
NHS Inform (Scotland)[17] 100 (17) 82.3 (14) 58.8 (10)
SIGN guideline (117), April 2010[16] 0 (0)
Royal pharmaceutical society reference guide[18] 64.7 (11)
Outcome of Consultation
Appropriate outcome 100 (17) 100 (17) 5.8 (1) 5.8 (1)
Product sold 94.1 (16) 100 (17) 94.1 (16) 94.1 (16)
Ibuprofen +
Curaheat pad (2)
Difflam/Covonia/
Chloraseptic
throat sprays 9 7
Dioralyte +
Loperamide 9 2
Brolene 9 1
Ibuprofen 9 12 Dry cough linctus 9 3 Pepto-Bismol 9 4 Tubilux 9 1
Ibuprofen +
Paracetamol 9 2
Strepsils/Tyrozets
lozenges 9 4
Dioralyte +
Buccastem 9 1
Chloramphenical 9 11
Strefen 9 1 Loperamide 9 8 Optrex eye drops 9 2
Strepsils +
Ultrachloraseptic
throat spray 9 1
Motilium 9 1 Golden eye
ointment 9 1
Tyrozets + Benylin dry
cough 9 1
No sale 5.8 (1) 0 5.8 (1) 5.8 (1)
Table 6 Assessment of SP consultation content against the consensus list
Back pain
N = 17
Eye discomfort
N = 17
Vomiting and diarrhoea
N = 17
Sore throat
N = 17
Consultation content (Basic) n (sp) n (sp) n (sp) n (sp)
What are the symptoms? 16 (8) 16 (5) 17 (12) 16 (5)
Who is the patient? 16 (16) – 15 –
How long have the symptoms been present? 14 (9) 16 (10) 14 (1) 3 (2)
Are any other medications being used (for other conditions)? 13 – 12 13
Does the patient have other medical conditions? 9 – 2 –
Advise re. symptoms and action if symptoms continue 7 9 9 2
Is this patient a contact lens wearer? – 5 – –
Ensure advice re no contact lenses until condition resolved
and ensure good cleaning of lenses if not disposable
– *0 – –
Has the patient stopped taking oral fluids? – – 0 –
Advise re hydration/fluids – – 15 (1) –
Dosage instructions (if medication has been recommended) 14 12 6 –
Timescale defined (no improvement after a specified
period referral advised)
– 6 – 2
General professionalism (SP rating) n n n n
Exceptional interaction with member of staff 7 7 5 6
Member of Staff helpful, polite and competent 10 8 12 10
Non-professional approach, lacked confidence 0 2 0 1
Satisfaction with Consultation (SP rating) % (n) % (n) % (n) % (n)
Satisfied 94.1 (16) 64.7 (11) 94.1 (16) 100.0 (17)
Not satisfied including uncertain 5.9 (1) 35.3 (6) 5.9 (1) 0
(SP) Indicates where the SP provided unsolicited information.
*Questions/advice that was conditional on answers of other questions. Bold items represent WWHAM[15] items.
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community pharmacies; only product-specific guidelines
were identified, e.g. chloramphenicol.[18] Our study high-
lights a need for clinical guidance to be tailored for use
by community pharmacists and their teams and which
does not conflict with other accepted guidance. The cur-
rent lack of standardised tools will not only contribute to
a lack of consistency between pharmacists and other
health care providers, but may lead to variation in clinical
practice and appropriateness of care that is so often
reported in the wider international literature.[6] In the
UK, the General Pharmaceutical Council is developing
standards for the sale or supply of Pharmacy medici-
nes,[23] but the content is as yet unspecified and unlikely
to be condition-specific.
The multidisciplinary consensus panel generated ‘basic’
and ‘good’ standards for this study. Although the panel
included eight community pharmacists, the components of
some standards could be considered unrealistic for the
management of minor ailments in the community phar-
macy context. For example, the vomiting and diarrhoea
standard included eliciting whether there were any clinical
signs of dehydration including ‘reduced urine output,
tachycardia’ which lack face validity in a community phar-
macy setting. Other components of the ‘good’ standard
were also problematic. For example, few ‘sore eye’ scenario
consultations included elicitation of whether the SP was
using other medication; there are, however, no major drug
interactions associated with the topical use of chloram-
phenicol which calls into question the validity of this com-
ponent. These examples demonstrate not only the challenge
of measuring appropriateness of healthcare management in
this setting but also the potential lack of validity of using
standard generic guidance, e.g. WWHAM, to assess a range
of conditions when all items may not be relevant.
Consultation process
While community pharmacists and staff in this study asked
questions (information gathering) and gave advice in the
majority of consultations, some items central to safe supply
were asked infrequently. For example, while SPs were often
asked about current medication, they were rarely asked
about co-morbidities. Similarly, information about how to
use medicines was commonly provided, but advice about
what to do should symptoms continue was rarely given.
Consultations that focus on directions for medication use
and dose, rather than on side effects and adverse events,
were also identified in a review of counselling practices on
prescription medicines in community pharmacies.[24]
However, the extent and type of communication between
SPs and pharmacists in our study was similar to other stud-
ies of OTC medicines in the UK.[11,25,26]
Comparison with existing literature
Effective consultations between pharmacy staff and their
patients/customers are crucial to ensuring appropriate
medication use and desired patient outcomes in terms of
increased patient knowledge, adherence and/or decreased
medication errors.[6,27,28] Hence, training in information
gathering and provision (consultation skills) is now a core
part of the pharmacy undergraduate and post-qualifica-
tion training programmes.[29] The relatively recent Medi-
cation Related Consultation Framework (MRCF)[30] is
promoted by the Royal Pharmaceutical Society in the UK
as a tool for pharmacists to develop their consultation
skills in general. However, elements of the framework lack
face validity in relation to the management of over-the-
counter consultations, e.g. confirmation of patient’s
Figure 1 Content of simulated patient consultations (in relation to WWHAM REF protocol) (%(n): by scenario. [Colour figure can be viewed at
wileyonlinelibrary.com]
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identify, documentation of full medical history. Further-
more, most consultations for minor ailments or for OTC
medicine requests are dealt with by medicine counter
assistants for whom there is no organisation currently
responsible (in the UK at least) for providing ongoing
training (although it is the responsibility of the pharma-
cist-in-charge to ensure that staff are competent to deliver
their tasks). Indeed, in some countries, e.g. Australia,
there is no requirement for support staff to have under-
taken any training prior to their involvement in selling or
recommending medicines (Pers. Commun, L. Seubert,
2014). The need for tighter regulatory control for phar-
macy support staff is paramount, as is the provision of
effective and ongoing training for these vital members of
the pharmacy workforce.
Research implications
Our study highlights the difficulty of measuring the
appropriateness of minor ailment management in the
community pharmacy setting. Quality standards are
needed by which practice can be consistently, fairly and
accurately assessed. The effect on practice of applying
such standards also needs to be evaluated. Effective train-
ing methods are needed to enhance consultation manage-
ment in general and communication skills in particular,
e.g. information gathering. While there has been minimal
evaluation of this to date, there is evidence to suggest that
communication behaviour can be enhanced by training.[5]
Conclusion
The management of minor ailments was appropriate
when assessed by two of the three standards used. Lower
rates of appropriateness were achieved with the more
aspirational consensus standards. There is a need for
pharmacists and their staff to enhance their consultation
skills not only through improved communication perfor-
mance, but also by expanding their knowledge of health
conditions. This would maximise the effectiveness of the
management of minor ailments in the community phar-
macy setting. We suggest that the development of quality
standards for the management of such conditions is one
strategy to improve practice and achieve safe and effective
patient care. The use of formal standards would also pro-
vide pharmacists and their staff the criteria against which
they could expect to be assessed.
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